1238 An open-label study of the pharmacokinetics, safety and tolerability of zibotentan (ZD4054) in subjects with mild, moderate, or severe renal impairment, or normal renal function

Saved in:
Bibliographic Details
Published inEuropean journal of cancer supplements Vol. 7; no. 2; p. 132
Main Authors Tomkinson, H.K, Weil, A, Engelhardt, E, Schmid, K, Oliver, S, Morris, T, Swaisland, H, Taboada, M
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 2009
Subjects
Hematology, Oncology and Palliative Medicine
Online AccessGet full text

Cover

More Information
ISSN:1359-6349
1878-1217
DOI:10.1016/S1359-6349(09)70450-1